Your browser doesn't support javascript.
loading
Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer.
Liu, Xinkui; Bai, Meirong; Li, Huiying; Ye, Peizhi; Duan, Xiaoxia; Wu, Chao; Huang, Zhihong; Lu, Shan; Zhang, Jingyuan; Zhao, Zihan; Guo, Fengying; You, Rongli; Qin, Wenjie; Wang, Wei; Han, Aiqing; Shen, Liangliang; Wang, Yitao; Zhao, Zheng; Luo, Hua; Wu, Jiarui.
Afiliación
  • Liu X; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
  • Bai M; Key Laboratory of Mongolian Medicine Research and Development Engineering, Ministry of Education, Tongliao, China.
  • Li H; College of Biological Sciences and Technology, Beijing Key Laboratory of Food Processing and Safety in Forestry, Beijing Forestry University, Beijing, China.
  • Ye P; National Cancer Center, National Clinical Research Center for Cancer, Chinese Medicine Department of the Cancer Hospital of the Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Duan X; Beijing Zest Bridge Medical Technology Inc., Beijing, China.
  • Wu C; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
  • Huang Z; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
  • Lu S; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
  • Zhang J; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
  • Zhao Z; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
  • Guo F; School of Management, Beijing University of Chinese Medicine, Beijing, China.
  • You R; Beijing Zhendong Pharmaceutical Research Institute Co., Ltd., Beijing, China.
  • Qin W; Beijing Zhendong Pharmaceutical Research Institute Co., Ltd., Beijing, China.
  • Wang W; Beijing Zhendong Pharmaceutical Research Institute Co., Ltd., Beijing, China.
  • Han A; School of Management, Beijing University of Chinese Medicine, Beijing, China.
  • Shen L; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
  • Wang Y; Macau Centre for Research and Development in Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, Macao SAR, China.
  • Zhao Z; Beijing Zest Bridge Medical Technology Inc., Beijing, China.
  • Luo H; Macau Centre for Research and Development in Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, Macao SAR, China.
  • Wu J; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
Front Immunol ; 13: 965342, 2022.
Article en En | MEDLINE | ID: mdl-36389835
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China